Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Vehicle-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of AN2690 Topical Solution, 5%, vs. Solution Vehicle in the Treatment of Onychomycosis of the Toenail in Adults
Conditions
Interventions
AN2690 Topical Solution, 5%
Solution Vehicle
Locations
32
United States
Investigational Site
Phoenix, Arizona, United States
Investigational Site
Novato, California, United States
Investigational Site
Oceanside, California, United States
Investigational Site
San Diego, California, United States
Investigational Site
San Francisco, California, United States
Investigational Site
Santa Rosa, California, United States
Start Date
February 1, 2011
Primary Completion Date
December 31, 2012
Completion Date
February 20, 2013
Last Updated
April 3, 2019
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions